DekaBank Deutsche Girozentrale’s Lexicon Pharmaceuticals LXRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-76,282
| Closed | -$465K | – | 1072 |
|
2019
Q2 | $465K | Sell |
76,282
-32,159
| -30% | -$196K | ﹤0.01% | 930 |
|
2019
Q1 | $1.27M | Buy |
108,441
+26,022
| +32% | +$306K | 0.01% | 711 |
|
2018
Q4 | $528K | Sell |
82,419
-26,022
| -24% | -$167K | ﹤0.01% | 819 |
|
2018
Q3 | $1.27M | Sell |
108,441
-1,000
| -0.9% | -$11.7K | 0.01% | 723 |
|
2018
Q2 | $1.36M | Buy |
109,441
+2,000
| +2% | +$24.8K | 0.01% | 679 |
|
2018
Q1 | $899K | Sell |
107,441
-36,000
| -25% | -$301K | 0.01% | 745 |
|
2017
Q4 | $2.08M | Hold |
143,441
| – | – | 0.02% | 536 |
|
2017
Q3 | $2.08M | Hold |
143,441
| – | – | 0.02% | 544 |
|
2017
Q2 | $2.37M | Buy |
+143,441
| New | +$2.37M | 0.02% | 514 |
|
2016
Q3 | – | Sell |
-51,741
| Closed | -$735K | – | 998 |
|
2016
Q2 | $735K | Buy |
51,741
+7,100
| +16% | +$101K | 0.01% | 596 |
|
2016
Q1 | $549K | Sell |
44,641
-8,100
| -15% | -$99.6K | 0.01% | 638 |
|
2015
Q4 | $705K | Buy |
52,741
+600
| +1% | +$8.02K | 0.01% | 625 |
|
2015
Q3 | $560K | Buy |
52,141
+1,300
| +3% | +$14K | 0.01% | 672 |
|
2015
Q2 | $409K | Sell |
50,841
-288,559
| -85% | -$2.32M | ﹤0.01% | 739 |
|
2015
Q1 | $320K | Buy |
339,400
+63,500
| +23% | +$59.9K | ﹤0.01% | 813 |
|
2014
Q4 | $239K | Sell |
275,900
-25,500
| -8% | -$22.1K | ﹤0.01% | 827 |
|
2014
Q3 | $425K | Buy |
301,400
+6,000
| +2% | +$8.46K | 0.01% | 693 |
|
2014
Q2 | $476K | Sell |
295,400
-17,000
| -5% | -$27.4K | 0.01% | 604 |
|
2014
Q1 | $540K | Buy |
312,400
+20,000
| +7% | +$34.6K | 0.01% | 564 |
|
2013
Q4 | $529K | Buy |
292,400
+6,000
| +2% | +$10.9K | 0.01% | 535 |
|
2013
Q3 | $682K | Buy |
+286,400
| New | +$682K | 0.01% | 503 |
|